# US 2015/0104807 A1 · Kits for diagnostic and therapeutic uses of augmenter of liver regeneration in inflammatory conditions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0104807 A1
- Document ID: US20150104807A1
- Status: Published application
- Kind: A1
- Application number: 14/463,481
- Filed: 2014-08-19
- Published: 2015-04-16
- Earliest claimed: 2007-09-07
- Assignees: University of Pittsburgh—Of the Commonwealth System of Higher Education
- Applicants: University of Pittsburgh - of the Commonwealth System of Higher Education
- Inventors: CHANRASHEKHAR R. GANDHI; Yoram Vodovotz
- Web page: https://patentgrep.com/patent/US20150104807A1

## CPC

- G01N 33/573: for enzymes or isoenzymes
- A61K 31/00: Medicinal preparations containing organic active ingredients
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C07K 16/18: against material from animals or humans
- C07K 16/22: against growth factors {; against growth regulators}
- C12N 15/113: Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)}
- G01N 33/6893: {related to diseases not provided for elsewhere}
- A01K 2207/20: Animals treated with compounds which are neither proteins nor nucleic acids
- A01K 2207/30: Animals modified by surgical methods
- A01K 2227/105: Murine
- A01K 2267/0337: Animal models for infectious diseases
- C12N 2310/11: Antisense
- G01N 2333/71: for growth factors; for growth regulators
- G01N 2333/90212: acting on a sulfur group of donors (1.8)
- G01N 2800/24: Immunology or allergic disorders
- G01N 2800/26: Infectious diseases, e.g. generalised sepsis
- G01N 2800/7095: Inflammation
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A01K: ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS

## Abstract

The present invention provides for methods and kits for detecting sepsis, trauma/hemorrhage or inflammation in a subject. It is based, at least in part, on the discovery that Augmenter of Liver Regeneration (“ALR”) is an early marker of these conditions. Accordingly, in other embodiments, the present invention provides for a method of treating sepsis, traumatic/hemorrhagic shock and inflammation by inhibiting ALR.

## Claims

### Claim 1

A kit for detecting sepsis in a subject, comprising (i) a first antibody, or fragment thereof, which binds to Augmenter of Liver Regeneration (ii) a second antibody, which also binds to Augmenter of Liver Regeneration, linked to a detectable compound; and (iii) instructions that describe measuring the level of Augmenter of Liver Regeneration protein in a serum sample collected from a test human subject and comparing the level in the test subject to the serum level of Augmenter of Liver Regeneration protein in a healthy human control subject, wherein an elevation in the level of Augmenter of Liver Regeneration protein in the serum of the test subject compared with the control level is an indicator that the subject suffers from sepsis.

### Claim 2 (depends on 1)

The kit according to claim 1 where the first antibody is bound to a solid substrate.

### Claim 3 (depends on 1)

The kit according to claim 1 where the detectable compound is selected from the group consisting of a radioactive label, a fluorescent label, and an enzyme.

### Claim 4 (depends on 1)

The kit according to claim 1 where the detectable compound is a ligand and the kit further comprises a detector linked to a receptor for the ligand.

### Claim 5 (depends on 4)

The kit according to claim 4 where the detector is an enzyme and the kit further comprises a substrate for the enzyme, wherein the product of action of the enzyme on the substrate is detectable.

### Claim 6 (depends on 4)

The kit according to claim 4 where the ligand may be biotin or avidin.

### Claim 7 (depends on 5)

The kit according to claim 5 where the detector may be alkaline phosphatase.

### Claim 8 (depends on 2)

The kit according to claim 2 where the detectable compound is selected from the group consisting of a radioactive label, a fluorescent label, and an enzyme.

### Claim 9 (depends on 2)

The kit according to claim 2 where the detectable compound is a ligand and the kit further comprises a detector linked to a receptor for the ligand.

### Claim 10 (depends on 9)

The kit according to claim 9 where the detector is an enzyme and the kit further comprises a substrate for the enzyme, wherein the product of action of the enzyme on the substrate is detectable.

### Claim 11 (depends on 9)

The kit according to claim 9 where the ligand may be biotin or avidin.

### Claim 12 (depends on 10)

The kit according to claim 10 where the detector may be alkaline phosphatase.

### Claim 13 (depends on 1)

The kit according to claim 1 where the first antibody or the second antibody is directed toward an Augmenter of Liver Regeneration protein region from MAAPG (SEQ ID NO:7) through KDGSCD (SEQ ID NO:6) of the human long-form Augmenter of Liver Regeneration protein sequence.

### Claim 14 (depends on 1)

The kit according to claim 1 where the first antibody or the second antibody is directed toward MRTQQKRTKFRED (SEQ ID NO:3).

### Claim 15 (depends on 2)

The kit according to claim 2 where the first antibody or the second antibody is directed toward an Augmenter of Liver Regeneration protein region from MAAPG (SEQ ID NO:7) through KDGSCD (SEQ ID NO:6) of the human long-form Augmenter of Liver Regeneration protein sequence.

### Claim 16 (depends on 2)

The kit according to claim 2 where the first antibody or the second antibody is directed toward MRTQQKRTKFRED (SEQ ID NO:3).

### Claim 17

A kit for detecting inflammation in a subject, comprising (i) a first antibody, or fragment thereof, which binds to Augmenter of Liver Regeneration (ii) a second antibody, which also binds to Augmenter of Liver Regeneration, linked to a detectable compound; and (iii) instructions that describe measuring the level of Augmenter of Liver Regeneration protein in a serum sample collected from a test human subject and comparing the level in the test subject to the serum level of Augmenter of Liver Regeneration protein in a healthy human control subject, wherein an elevation in the level of Augmenter of Liver Regeneration protein in the serum of the test subject compared with the control level is an indicator that the subject suffers from inflammation.

### Claim 18 (depends on 17)

The kit according to claim 17 where the first antibody is bound to a solid substrate.

### Claim 19 (depends on 17)

The kit according to claim 17 where the first antibody or the second antibody is directed toward an Augmenter of Liver Regeneration protein region from MAAPG (SEQ ID NO:7) through KDGSCD (SEQ ID NO:6) of the human long-form Augmenter of Liver Regeneration protein sequence.

### Claim 20 (depends on 17)

The kit according to claim 17 where the first antibody or the second antibody is directed toward MRTQQKRTKFRED (SEQ ID NO:3).
